Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Lapaquistat Acetate with Ezetimibe in Primary Dyslipidemia
NCT00268697Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lapaquistat in hypercholesterolemia, sponsored by Takeda. Started Oct 2005; status: completed.
02
Drugs
lapaquistat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00268697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268697.